Donaco International Limited (ASX:DNA) (FRA:UGS) has announced its results for the six month period ended 31 December 2020 (1H FY21) and Investor Presenation.
Games & Entertainment
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce the Company's results for the half-year ended 31 December 2020.
PlayUp Limited is pleased to announce it has successfully completed a significantly over subscribed private capital raising of A$12.5 million ("Capital Raising").
Donaco International Limited (ASX:DNA) (FRA:UGS) will host an investor briefing to discuss the Company's Half Year Results at 3:00pm (AEDT)/11:00am (ICT) on Friday, 26 February 2021.
The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is delighted to announce that it has entered into an agreement which will see online wagering industry leader Matt Tripp partner exclusively with BetMakers to accelerate growth of its B2B wagering strategy.
Premium entertainment and technology group, PlayUp Ltd., today announced the purchase of Australia's leading fan and athlete media platforms, The Roar and AthletesVoice.
Donaco International Limited (ASX:DNA) (FRA:UGS) provides the following trading update for the three-month period ending 31 December 2020.
Banking & Finance
- Troy Duran Interviews Dr. Eric Jensen of EMX Royalty and Ellis Martin of Martin Laboratories Optioning 5 Battery Metals Projects in Scandinavia.
- Resolution Minerals Ltd (ASX:RML) Positive Revision of JV Agreement for 64North Project Alaska
- Ellis Martin Report: EMX Royalty Corp's Dr. Eric Jensen on Contrarian Investments that Can Pay Off (NYSE:EMX)
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Quarterly Webinar Presentation
- Deep Yellow Limited (ASX:DYL) A$40.8M Placement Successfully Completed
- Central Petroleum Limited (ASX:CTP) Half Year Results - Reports $2.5 Million Net Profit
- Beroni Group Limited (NSX:BTG) Appointment of Non-Executive Director
- BPH Energy Limited (ASX:BPH) Advent Commissions Environmental Review
- Ellis Martin Report: Entheon Biomedical (CNSX:ENBI) CEO Timothy Ko on the Ethical Clinical Use of DMT for Treating Substance Abuse, Depression, Anxiety and More